0.2322

0.09% -0.0002

After Hours: .23 -0.0022 -0.95%

Intensity Therapeutics Inc (INTS)

Overview News Price History Financials Why INTS Down? Discussions Forecast

Intensity Therapeutics Inc stock is traded at $0.2322, with a volume of 1.82M. It is down -0.09% in the last 24 hours and down -20.97% over the past month. Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Previous Close:

$0.2324

Open:

$0.23

24h Volume:

1.82M

Relative Volume:

0.43

Market Cap:

$11.34M

Revenue:

Net Income/Loss:

$-16.26M

P/E Ratio:

-0.1965

EPS:

-1.1814

Net Cash Flow:

$-13.50M

1W Performance:

-17.69%

1M Performance:

-20.97%

6M Performance:

-90.08%

1Y Performance:

-94.47%

1-Day Range:

$0.2256

$0.245

1-Week Range:

$0.2256

$0.2978

52-Week Range:

$0.1853

$4.25

Intensity Therapeutics Inc Stock (INTS) Company Profile

Name

Intensity Therapeutics Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

203-221-7381

Address

1 ENTERPRISE DRIVE, SUITE 430, SHELTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

INTS's Discussions on Twitter

Compare INTS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INTS Intensity Therapeutics Inc	0.2322	12.05M	0	-16.26M	-13.50M	-1.1814
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Intensity Therapeutics Inc (INTS)

Intensity Therapeutics Inc Stock (INTS) Company Profile

Compare INTS with other stocks

Intensity Therapeutics Inc Stock (INTS) Latest News

What moving averages say about Intensity Therapeutics Inc.Market Volume Summary & Real-Time Price Movement Reports - Newser

Will Intensity Therapeutics Inc. continue its uptrendWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - Newser

How moving averages guide Intensity Therapeutics Inc. tradingEarnings Beat & Accurate Entry and Exit Point Alerts - Newser

Is Intensity Therapeutics Inc. building a consolidation baseJuly 2025 Institutional & Weekly Top Performers Watchlists - Newser

Published on: 2025-09-12 14:49:46 - Newser

Price momentum metrics for Intensity Therapeutics Inc. explainedLayoff News & Community Consensus Stock Picks - Newser

Using portfolio simulators with Intensity Therapeutics Inc. includedQuarterly Performance Summary & Technical Entry and Exit Tips - Newser

Measuring Intensity Therapeutics Inc.’s beta against major indices2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser

What the charts say about Intensity Therapeutics Inc. today2025 Valuation Update & High Yield Stock Recommendations - Newser

Trend analysis for Intensity Therapeutics Inc. this weekJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser

What earnings revisions data tells us about Intensity Therapeutics Inc.Rate Cut & Weekly Market Pulse Updates - Newser

Intensity Therapeutics Inc. stock prediction for this weekWeekly Trend Summary & AI Enhanced Market Trend Forecasts - Newser

Will Intensity Therapeutics Inc. outperform the marketCPI Data & Free Daily Entry Point Trade Alerts - Newser

Intensity Therapeutics Inc. stock trend forecastProduct Launch & Free Community Supported Trade Ideas - Newser

Will Intensity Therapeutics Inc. stock go up soonMarket Performance Summary & Daily Momentum Trading Reports - Newser

Intensity Therapeutics Inc.’s volatility index tracking explainedOil Prices & Weekly Watchlist of Top Performers - Newser

Analyzing Intensity Therapeutics Inc. with multi timeframe chartsJuly 2025 Volume & Fast Gaining Stock Reports - Newser

Is a relief rally coming for Intensity Therapeutics Inc. holdersQuarterly Portfolio Report & Low Risk Investment Opportunities - Newser

intensity therapeutics inc. stock prediction for this week2025 Winners & Losers & High Accuracy Trade Alerts - Newser

Statistical indicators supporting Intensity Therapeutics Inc.’s strengthQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser

Developing predictive dashboards with Intensity Therapeutics Inc. dataInsider Buying & Stock Portfolio Risk Control - Newser

How to recover losses in Intensity Therapeutics Inc. stock2025 Momentum Check & Daily Stock Trend Reports - Newser

What MACD and RSI say about Intensity Therapeutics Inc.July 2025 Trends & Risk Controlled Daily Trade Plans - Newser

Intensity Therapeutics Inc. stock daily chart insightsJobs Report & Free AI Powered Buy and Sell Recommendations - Newser

Tools to monitor Intensity Therapeutics Inc. recovery probabilityQuarterly Market Summary & Free High Return Stock Watch Alerts - Newser

What to expect from Intensity Therapeutics Inc. in the next 30 daysQuarterly Market Review & Risk Managed Investment Strategies - Newser

How to interpret RSI for Intensity Therapeutics Inc. stockJuly 2025 Intraday Action & Community Consensus Trade Alerts - Newser

Intensity Therapeutics Pauses Enrollment in INVINCIBLE-4 Study - TipRanks

Intensity Therapeutics: Invincible-4 TNBC trial update - MarketScreener

Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update - 富途牛牛

Multi asset correlation models including Intensity Therapeutics Inc. - Newser

Using data filters to optimize entry into Intensity Therapeutics Inc.Quarterly Investment Review & Advanced Technical Signal Analysis - Newser

Analyzing recovery setups for Intensity Therapeutics Inc. investorsJuly 2025 Technicals & Fast Moving Trade Plans - Newser

Intensity Therapeutics Inc Stock (INTS) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to INTS